Pub. Date : 2019 Nov
PMID : 31642025
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Upadacitinib (Rinvoq ), an orally-administered Janus kinase 1 (JAK-1) inhibitor, is being developed by AbbVie for the treatment of rheumatoid arthritis. | upadacitinib | Janus kinase 1 | Homo sapiens |
| 2 | Upadacitinib (Rinvoq ), an orally-administered Janus kinase 1 (JAK-1) inhibitor, is being developed by AbbVie for the treatment of rheumatoid arthritis. | upadacitinib | Janus kinase 1 | Homo sapiens |